What changed

B100490/2025

P10_TA(2025)0290

European Parliament resolution on the draft Commission implementing decision renewing the authorisation for the placing on the market of products containing, consisting of or produced from genetically modified oilseed rape MON 88302, pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council

Genetically modified oilseed rape MON 88302

(D109632/01 – 2025/2895(RSP))

PE778.109

European Parliament resolution of 25 November 2025 on the draft Commission implementing decision renewing the authorisation for the placing on the market of products containing, consisting of or produced from genetically modified oilseed rape MON 88302, pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council (D109632/01 – 2025/2895(RSP))

The European Parliament,

– having regard to Regulation (EC) No 1829/2003 of the European Parliament and of the Council of 22 September 2003 on genetically modified food and feed , and in particular Article 11(3) and Article 23(3) thereof,

– having regard to the vote of the Standing Committee on Plants, Animals, Food and Feed referred to in Article 35 of Regulation (EC) No 1829/2003, on 15 September 2025, at which no opinion was delivered, and the vote of the Appeal Committee on 21 October 2025, at which again no opinion was delivered,

– having regard to Article 11 of Regulation (EU) No 182/2011 of the European Parliament and of the Council of 16 February 2011 laying down the rules and general principles concerning mechanisms for control by Member States of the Commission’s exercise of implementing powers,

– having regard to the motion for a resolution of the Committee on the Environment, Climate and Food Safety,

A. whereas Commission Implementing Decision (EU) 2015/687 of 24 April 2015 authorised the placing on the market of products containing, consisting of or produced from genetically modified oilseed rape MON 88302 (the ‘GM oilseed rape);rape’);

B. whereas on 28 February 2024, Bayer Agriculture B.V., based in Belgium, on behalf of Bayer CropScience LP, based in the United States of America, submitted an application to the Commission, in accordance with Articles 11 and 23 of Regulation (EC) No 1829/2003, for the renewal of that authorisation; whereas the scope of that authorisation also covers the placing on the market of products, other than food and feed, containing or consisting of the GM oilseed rape for the same uses as any other oilseed rape, with the exception of cultivation;

I. whereas Regulation (EC) No 1829/2003 requires that GM food and feed must not have adverse effects on human health, animal health or the environment;

K.J. whereas the One Health approach requires an integrated view of risks and impacts across human, animal, plant and environmental health, which is not ensured in the current assessment;

L.K. whereas Parliament has repeatedly objected to the authorisation or renewal of GMOs in cases where no qualified majority is reached among Member States in the Standing Committee on Plants, Animals, Food and Feed or the Appeal Committee, underlining the persistent democratic deficit in the authorisation procedure;

1. Considers that the draft Commission implementing decision exceeds the implementing powers provided for in Regulation (EC) No 1829/2003;